Cargando…

Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases

BACKGROUND: Relapsing polychondritis (RP) is a rare inflammatory disease characterized by recurrent inflammation and destruction of cartilaginous tissues. RP has characteristics of autoimmune disease and some reports have noted co-occurrence with autoimmune thyroid disease (AITD), consisting of Grav...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Toshiki, Yoshifuji, Hajime, Yamano, Yoshihisa, Yurugi, Kimiko, Miura, Yasuo, Maekawa, Taira, Yoshida, Tsuneyasu, Handa, Hiroshi, Ohmura, Koichiro, Mimori, Tsuneyo, Terao, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087919/
https://www.ncbi.nlm.nih.gov/pubmed/35534869
http://dx.doi.org/10.1186/s13023-022-02261-5
_version_ 1784704259438149632
author Nakajima, Toshiki
Yoshifuji, Hajime
Yamano, Yoshihisa
Yurugi, Kimiko
Miura, Yasuo
Maekawa, Taira
Yoshida, Tsuneyasu
Handa, Hiroshi
Ohmura, Koichiro
Mimori, Tsuneyo
Terao, Chikashi
author_facet Nakajima, Toshiki
Yoshifuji, Hajime
Yamano, Yoshihisa
Yurugi, Kimiko
Miura, Yasuo
Maekawa, Taira
Yoshida, Tsuneyasu
Handa, Hiroshi
Ohmura, Koichiro
Mimori, Tsuneyo
Terao, Chikashi
author_sort Nakajima, Toshiki
collection PubMed
description BACKGROUND: Relapsing polychondritis (RP) is a rare inflammatory disease characterized by recurrent inflammation and destruction of cartilaginous tissues. RP has characteristics of autoimmune disease and some reports have noted co-occurrence with autoimmune thyroid disease (AITD), consisting of Graves’ disease (GD) and Hashimoto thyroiditis (HT). However, there have been no detailed studies on the co-occurrence of RP and AITD. In this study, we aimed to determine whether patients with RP tend to be complicated with AITD. We also analyzed the clinical and genetic profiles of patients in whom these diseases co-occur. METHODS: We recruited 117 patients with RP and reviewed their medical records. Furthermore, we genotyped Human Leucocyte Antigen (HLA)-A, B Cw, DRB1, DQB1, and DPB1 alleles for 93 of the 117 patients. The prevalence of AITD among the patients with RP was compared with that among the general Japanese population. We also analyzed the clinical and genetic features of the patients with both RP and AITD. RESULTS: The prevalence of GD among the patients with RP was 4.3% (5 among 117 patients), significantly higher than that among Japanese (0.11%) (p = 2.44 × 10(–7), binomial test). RP patients with GD tended to have nasal involvement (p = 0.023) (odds ratio (OR) 2.58) and HLA-DPB1*02:02 (p = 0.035, OR 10.41). We did not find significant enrichment of HT in patients with RP. CONCLUSIONS: Patients with RP appear to be at elevated risk of GD. Nasal involvement and HLA-DPB1*02:02 characterize the subset of RP patients with GD, which may guide attempts to characterize a distinct subtype of RP for precision medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02261-5.
format Online
Article
Text
id pubmed-9087919
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90879192022-05-11 Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases Nakajima, Toshiki Yoshifuji, Hajime Yamano, Yoshihisa Yurugi, Kimiko Miura, Yasuo Maekawa, Taira Yoshida, Tsuneyasu Handa, Hiroshi Ohmura, Koichiro Mimori, Tsuneyo Terao, Chikashi Orphanet J Rare Dis Research BACKGROUND: Relapsing polychondritis (RP) is a rare inflammatory disease characterized by recurrent inflammation and destruction of cartilaginous tissues. RP has characteristics of autoimmune disease and some reports have noted co-occurrence with autoimmune thyroid disease (AITD), consisting of Graves’ disease (GD) and Hashimoto thyroiditis (HT). However, there have been no detailed studies on the co-occurrence of RP and AITD. In this study, we aimed to determine whether patients with RP tend to be complicated with AITD. We also analyzed the clinical and genetic profiles of patients in whom these diseases co-occur. METHODS: We recruited 117 patients with RP and reviewed their medical records. Furthermore, we genotyped Human Leucocyte Antigen (HLA)-A, B Cw, DRB1, DQB1, and DPB1 alleles for 93 of the 117 patients. The prevalence of AITD among the patients with RP was compared with that among the general Japanese population. We also analyzed the clinical and genetic features of the patients with both RP and AITD. RESULTS: The prevalence of GD among the patients with RP was 4.3% (5 among 117 patients), significantly higher than that among Japanese (0.11%) (p = 2.44 × 10(–7), binomial test). RP patients with GD tended to have nasal involvement (p = 0.023) (odds ratio (OR) 2.58) and HLA-DPB1*02:02 (p = 0.035, OR 10.41). We did not find significant enrichment of HT in patients with RP. CONCLUSIONS: Patients with RP appear to be at elevated risk of GD. Nasal involvement and HLA-DPB1*02:02 characterize the subset of RP patients with GD, which may guide attempts to characterize a distinct subtype of RP for precision medicine. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02261-5. BioMed Central 2022-05-10 /pmc/articles/PMC9087919/ /pubmed/35534869 http://dx.doi.org/10.1186/s13023-022-02261-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Nakajima, Toshiki
Yoshifuji, Hajime
Yamano, Yoshihisa
Yurugi, Kimiko
Miura, Yasuo
Maekawa, Taira
Yoshida, Tsuneyasu
Handa, Hiroshi
Ohmura, Koichiro
Mimori, Tsuneyo
Terao, Chikashi
Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases
title Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases
title_full Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases
title_fullStr Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases
title_full_unstemmed Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases
title_short Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases
title_sort co-occurrence of relapsing polychondritis and autoimmune thyroid diseases
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087919/
https://www.ncbi.nlm.nih.gov/pubmed/35534869
http://dx.doi.org/10.1186/s13023-022-02261-5
work_keys_str_mv AT nakajimatoshiki cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT yoshifujihajime cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT yamanoyoshihisa cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT yurugikimiko cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT miurayasuo cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT maekawataira cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT yoshidatsuneyasu cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT handahiroshi cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT ohmurakoichiro cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT mimoritsuneyo cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases
AT teraochikashi cooccurrenceofrelapsingpolychondritisandautoimmunethyroiddiseases